13-45702806-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152719.3(CBY2):āc.107A>Gā(p.Asp36Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,614,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152719.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBY2 | NM_152719.3 | c.107A>G | p.Asp36Gly | missense_variant | 2/3 | ENST00000310521.6 | NP_689932.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBY2 | ENST00000310521.6 | c.107A>G | p.Asp36Gly | missense_variant | 2/3 | 1 | NM_152719.3 | ENSP00000309189.1 | ||
CBY2 | ENST00000610924.1 | c.-34+291A>G | intron_variant | 5 | ENSP00000480148.1 | |||||
CBY2 | ENST00000533564.1 | c.75+341A>G | intron_variant | 2 | ENSP00000435230.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251386Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135868
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727188
GnomAD4 genome AF: 0.000105 AC: 16AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.107A>G (p.D36G) alteration is located in exon 2 (coding exon 2) of the SPERT gene. This alteration results from a A to G substitution at nucleotide position 107, causing the aspartic acid (D) at amino acid position 36 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at